TY - JOUR AU - Bourne, R. R. AU - Stevens, G. A. AU - White, R. A. AU - Smith, J. L. AU - Flaxman, S. R. AU - Price, H. PY - 2013 DA - 2013// TI - Causes of vision loss worldwide, 1990-2010: a systematic analysis JO - Lancet Glob Health VL - 1 ID - Bourne2013 ER - TY - JOUR AU - Colijn, J. M. AU - Buitendijk, G. H. S. AU - Prokofyeva, E. AU - Alves, D. AU - Cachulo, M. L. AU - Khawaja, A. P. PY - 2017 DA - 2017// TI - Prevalence of age-related macular degeneration in Europe: the past and the future JO - Ophthalmology VL - 124 ID - Colijn2017 ER - TY - JOUR AU - Lim, L. S. AU - Mitchell, P. AU - Seddon, J. M. AU - Holz, F. G. AU - Wong, T. Y. PY - 2012 DA - 2012// TI - Age-related macular degeneration JO - Lancet VL - 379 ID - Lim2012 ER - TY - JOUR AU - Wong, T. Y. AU - Chakravarthy, U. AU - Klein, R. AU - Mitchell, P. AU - Zlateva, G. AU - Buggage, R. PY - 2008 DA - 2008// TI - The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis JO - Ophthalmology VL - 115 ID - Wong2008 ER - TY - JOUR AU - Solomon, S. D. AU - Lindsley, K. AU - Vedula, S. S. AU - Krzystolik, M. G. AU - Hawkins, B. S. PY - 2019 DA - 2019// TI - Anti-vascular endothelial growth factor for neovascular age-related macular degeneration JO - Cochrane Database Syst Rev VL - 3 ID - Solomon2019 ER - TY - STD TI - Li JQ, Welchowski T, Schmid M, Mauschitz MM, Holz FG, Finger RP. Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis. Br J Ophthalmol. 2019. https://doi.org/10.1136/bjophthalmol-2019-314422. ID - ref6 ER - TY - JOUR AU - Augood, C. A. AU - Vingerling, J. R. AU - Jong, P. T. AU - Chakravarthy, U. AU - Seland, J. AU - Soubrane, G. PY - 2006 DA - 2006// TI - Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE) JO - Arch Ophthalmol VL - 124 ID - Augood2006 ER - TY - JOUR AU - Finger, R. P. AU - Fimmers, R. AU - Holz, F. G. AU - Scholl, H. P. PY - 2011 DA - 2011// TI - Prevalence and causes of registered blindness in the largest federal state of Germany JO - Br J Ophthalmol VL - 95 ID - Finger2011 ER - TY - JOUR AU - Wong, W. L. AU - Su, X. AU - Li, X. AU - Cheung, C. M. AU - Klein, R. AU - Cheng, C. Y. PY - 2014 DA - 2014// TI - Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis JO - Lancet Glob Health VL - 2 ID - Wong2014 ER - TY - JOUR AU - Holz, F. G. AU - Strauss, E. C. AU - Schmitz-Valckenberg, S. AU - Lookeren Campagne, M. PY - 2014 DA - 2014// TI - Geographic atrophy: clinical features and potential therapeutic approaches JO - Ophthalmology VL - 121 ID - Holz2014 ER - TY - JOUR AU - Wu, Z. AU - Ayton, L. N. AU - Luu, C. D. AU - Guymer, R. H. PY - 2015 DA - 2015// TI - Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration JO - JAMA Ophthalmol VL - 133 ID - Wu2015 ER - TY - JOUR AU - Csaky, K. AU - Ferris, F. AU - Chew, E. Y. AU - Nair, P. AU - Cheetham, J. K. AU - Duncan, J. L. PY - 2017 DA - 2017// TI - Report from the NEI/FDA endpoints workshop on age-related macular degeneration and inherited retinal diseases JO - Invest Ophthalmol Vis Sci VL - 58 ID - Csaky2017 ER - TY - JOUR AU - Cocce, K. J. AU - Stinnett, S. S. AU - Luhmann, U. F. O. AU - Vajzovic, L. AU - Horne, A. AU - Schuman, S. G. PY - 2018 DA - 2018// TI - Visual function metrics in early and intermediate dry age-related macular degeneration for use as clinical trial endpoints JO - Am J Ophthalmol VL - 189 ID - Cocce2018 ER - TY - JOUR AU - Owsley, C. AU - McGwin, G. AU - Scilley, K. AU - Kallies, K. PY - 2006 DA - 2006// TI - Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy JO - Invest Ophthalmol Vis Sci VL - 47 ID - Owsley2006 ER - TY - JOUR AU - Wu, Z. AU - Guymer, R. H. AU - Finger, R. P. PY - 2015 DA - 2015// TI - Low luminance deficit and night vision symptoms in intermediate age-related macular degeneration JO - Br J Ophthalmol VL - 100 ID - Wu2015 ER - TY - JOUR AU - Dimitrov, P. N. AU - Robman, L. D. AU - Varsamidis, M. AU - Aung, K. Z. AU - Makeyeva, G. A. AU - Guymer, R. H. PY - 2011 DA - 2011// TI - Visual function tests as potential biomarkers in age-related macular degeneration JO - Invest Ophthalmol Vis Sci VL - 52 ID - Dimitrov2011 ER - TY - JOUR AU - Puell, M. C. AU - Barrio, A. R. AU - Palomo-Alvarez, C. AU - Gomez-Sanz, F. J. AU - Clement-Corral, A. AU - Perez-Carrasco, M. J. PY - 2012 DA - 2012// TI - Impaired mesopic visual acuity in eyes with early age-related macular degeneration JO - Invest Ophthalmol Vis Sci VL - 53 ID - Puell2012 ER - TY - JOUR AU - Finger, R. P. AU - Schmitz-Valckenberg, S. AU - Schmid, M. AU - Rubin, G. S. AU - Dunbar, H. AU - Tufail, A. PY - 2019 DA - 2019// TI - MACUSTAR: development and clinical validation of functional, structural, and patient-reported endpoints in intermediate age-related macular degeneration JO - Ophthalmologica VL - 241 ID - Finger2019 ER - TY - JOUR AU - Ferris, F. L. AU - Wilkinson, C. P. AU - Bird, A. AU - Chakravarthy, U. AU - Chew, E. AU - Csaky, K. PY - 2013 DA - 2013// TI - Clinical classification of age-related macular degeneration JO - Ophthalmology VL - 120 ID - Ferris2013 ER - TY - JOUR AU - Sevilla, M. B. AU - McGwin, G. AU - Lad, E. M. AU - Clark, M. AU - Yuan, E. L. AU - Farsiu, S. PY - 2016 DA - 2016// TI - Relating retinal morphology and function in aging and early to intermediate age-related macular degeneration subjects JO - Am J Ophthalmol VL - 165 ID - Sevilla2016 ER - TY - JOUR AU - Taylor, D. J. AU - Hobby, A. E. AU - Binns, A. M. AU - Crabb, D. P. PY - 2016 DA - 2016// TI - How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review JO - BMJ Open VL - 6 ID - Taylor2016 ER - TY - JOUR AU - Crossland, M. D. AU - Luong, V. A. AU - Rubin, G. S. AU - Fitzke, F. W. PY - 2011 DA - 2011// TI - Retinal specific measurement of dark-adapted visual function: validation of a modified microperimeter JO - BMC Ophthalmol VL - 11 ID - Crossland2011 ER - TY - JOUR AU - Rohrschneider, K. AU - Bultmann, S. AU - Springer, C. PY - 2008 DA - 2008// TI - Use of fundus perimetry (microperimetry) to quantify macular sensitivity JO - Prog Retin Eye Res VL - 27 ID - Rohrschneider2008 ER - TY - JOUR AU - Pfau, M. AU - Lindner, M. AU - Gliem, M. AU - Steinberg, J. S. AU - Thiele, S. AU - Finger, R. P. PY - 2018 DA - 2018// TI - Mesopic and dark-adapted two-color fundus-controlled perimetry in patients with cuticular, reticular, and soft drusen JO - Eye (Lond) VL - 32 ID - Pfau2018 ER - TY - JOUR AU - Steinberg, J. S. AU - Fitzke, F. W. AU - Fimmers, R. AU - Fleckenstein, M. AU - Holz, F. G. AU - Schmitz-Valckenberg, S. PY - 2015 DA - 2015// TI - Scotopic and photopic microperimetry in patients with reticular drusen and age-related macular degeneration JO - JAMA Ophthalmol VL - 133 ID - Steinberg2015 ER - TY - JOUR AU - Welker, S. G. AU - Pfau, M. AU - Heinemann, M. AU - Schmitz-Valckenberg, S. AU - Holz, F. G. AU - Finger, R. P. PY - 2018 DA - 2018// TI - Retest reliability of mesopic and dark-adapted microperimetry in patients with intermediate age-related macular degeneration and age-matched controls JO - Invest Ophthalmol Vis Sci VL - 59 ID - Welker2018 ER - TY - JOUR AU - Cassels, N. K. AU - Wild, J. M. AU - Margrain, T. H. AU - Chong, V. AU - Acton, J. H. PY - 2018 DA - 2018// TI - The use of microperimetry in assessing visual function in age-related macular degeneration JO - Surv Ophthalmol VL - 63 ID - Cassels2018 ER - TY - JOUR AU - Hsu, S. T. AU - Thompson, A. C. AU - Stinnett, S. S. AU - Luhmann, U. F. O. AU - Vajzovic, L. AU - Horne, A. PY - 2019 DA - 2019// TI - Longitudinal study of visual function in dry age-related macular degeneration at 12 months JO - Ophthalmol Retina VL - 3 ID - Hsu2019 ER - TY - JOUR AU - Owsley, C. AU - McGwin, G. AU - Clark, M. E. AU - Jackson, G. R. AU - Callahan, M. A. AU - Kline, L. B. PY - 2016 DA - 2016// TI - Delayed rod-mediated dark adaptation is a functional biomarker for incident early age-related macular degeneration JO - Ophthalmology VL - 123 ID - Owsley2016 ER - TY - JOUR AU - Jackson, G. R. AU - Clark, M. E. AU - Scott, I. U. AU - Walter, L. E. AU - Quillen, D. A. AU - Brigell, M. G. PY - 2014 DA - 2014// TI - Twelve-month natural history of dark adaptation in patients with AMD JO - Optom Vis Sci VL - 91 ID - Jackson2014 ER - TY - JOUR AU - Dimitrov, P. N. AU - Robman, L. D. AU - Varsamidis, M. AU - Aung, K. Z. AU - Makeyeva, G. AU - Busija, L. PY - 2012 DA - 2012// TI - Relationship between clinical macular changes and retinal function in age-related macular degeneration JO - Invest Ophthalmol Vis Sci VL - 53 ID - Dimitrov2012 ER - TY - JOUR AU - Sunness, J. S. AU - Rubin, G. S. AU - Broman, A. AU - Applegate, C. A. AU - Bressler, N. M. AU - Hawkins, B. S. PY - 2008 DA - 2008// TI - Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration JO - Ophthalmology VL - 115 ID - Sunness2008 ER - TY - JOUR AU - Shah, N. AU - Dakin, S. C. AU - Dobinson, S. AU - Tufail, A. AU - Egan, C. A. AU - Anderson, R. S. PY - 2016 DA - 2016// TI - Visual acuity loss in patients with age-related macular degeneration measured using a novel high-pass letter chart JO - Br J Ophthalmol VL - 100 ID - Shah2016 ER - TY - JOUR AU - Yehoshua, Z. AU - Wang, F. AU - Rosenfeld, P. J. AU - Penha, F. M. AU - Feuer, W. J. AU - Gregori, G. PY - 2011 DA - 2011// TI - Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography JO - Ophthalmology VL - 118 ID - Yehoshua2011 ER - TY - JOUR AU - Gregori, G. AU - Wang, F. AU - Rosenfeld, P. J. AU - Yehoshua, Z. AU - Gregori, N. Z. AU - Lujan, B. J. PY - 2011 DA - 2011// TI - Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration JO - Ophthalmology VL - 118 ID - Gregori2011 ER - TY - JOUR AU - Schaal, K. B. AU - Rosenfeld, P. J. AU - Gregori, G. AU - Yehoshua, Z. AU - Feuer, W. J. PY - 2016 DA - 2016// TI - Anatomic clinical trial endpoints for nonexudative age-related macular degeneration JO - Ophthalmology VL - 123 ID - Schaal2016 ER - TY - JOUR AU - Grinsven, M. J. AU - Lechanteur, Y. T. AU - Ven, J. P. AU - Ginneken, B. AU - Hoyng, C. B. AU - Theelen, T. PY - 2013 DA - 2013// TI - Automatic drusen quantification and risk assessment of age-related macular degeneration on color fundus images JO - Invest Ophthalmol Vis Sci VL - 54 ID - Grinsven2013 ER - TY - JOUR AU - Grinsven, M. J. AU - Buitendijk, G. H. AU - Brussee, C. AU - Ginneken, B. AU - Hoyng, C. B. AU - Theelen, T. PY - 2015 DA - 2015// TI - Automatic identification of reticular pseudodrusen using multimodal retinal image analysis JO - Invest Ophthalmol Vis Sci VL - 56 ID - Grinsven2015 ER - TY - JOUR AU - Venhuizen, F. G. AU - Ginneken, B. AU - Asten, F. AU - Grinsven, M. AU - Fauser, S. AU - Hoyng, C. B. PY - 2017 DA - 2017// TI - Automated staging of age-related macular degeneration using optical coherence tomography JO - Invest Ophthalmol Vis Sci VL - 58 ID - Venhuizen2017 ER - TY - JOUR AU - Russell, R. A. AU - Crabb, D. P. AU - Malik, R. AU - Garway-Heath, D. F. PY - 2012 DA - 2012// TI - The relationship between variability and sensitivity in large-scale longitudinal visual field data JO - Invest Ophthalmol Vis Sci VL - 53 ID - Russell2012 ER - TY - JOUR AU - Wu, Z. AU - Medeiros, F. A. PY - 2019 DA - 2019// TI - Sample size requirements of glaucoma clinical trials when using combined optical coherence tomography and visual field endpoints JO - Sci Rep VL - 9 ID - Wu2019 ER - TY - JOUR AU - Russell, R. A. AU - Malik, R. AU - Chauhan, B. C. AU - Crabb, D. P. AU - Garway-Heath, D. F. PY - 2012 DA - 2012// TI - Improved estimates of visual field progression using Bayesian linear regression to integrate structural information in patients with ocular hypertension JO - Invest Ophthalmol Vis Sci VL - 53 ID - Russell2012 ER - TY - JOUR AU - Lesko, L. J. AU - Atkinson, A. J. PY - 2001 DA - 2001// TI - Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies JO - Annu Rev Pharmacol Toxicol VL - 41 ID - Lesko2001 ER - TY - JOUR AU - Medeiros, F. A. PY - 2015 DA - 2015// TI - Biomarkers and surrogate endpoints in glaucoma clinical trials JO - Br J Ophthalmol VL - 99 ID - Medeiros2015 ER - TY - JOUR AU - Wickstrom, K. AU - Moseley, J. PY - 2017 DA - 2017// TI - Biomarkers and surrogate endpoints in drug development: a European regulatory view JO - Invest Ophthalmol Vis Sci VL - 58 ID - Wickstrom2017 ER - TY - JOUR AU - Fleming, T. R. AU - DeMets, D. L. PY - 1996 DA - 1996// TI - Surrogate end points in clinical trials: are we being misled? JO - Ann Intern Med VL - 125 ID - Fleming1996 ER - TY - JOUR AU - Psaty, B. M. AU - Weiss, N. S. AU - Furberg, C. D. AU - Koepsell, T. D. AU - Siscovick, D. S. AU - Rosendaal, F. R. PY - 1999 DA - 1999// TI - Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease JO - JAMA VL - 282 ID - Psaty1999 ER - TY - JOUR AU - Prentice, R. L. PY - 1989 DA - 1989// TI - Surrogate endpoints in clinical trials: definition and operational criteria JO - Stat Med VL - 8 ID - Prentice1989 ER - TY - JOUR AU - Heller, G. PY - 2015 DA - 2015// TI - Statistical controversies in clinical research: an initial evaluation of a surrogate end point using a single randomized clinical trial and the Prentice criteria JO - Ann Oncol VL - 26 ID - Heller2015 ER -